Wang et al. found that up regulation of TWIST1 was responsible for the development of acquired paclitaxel-resistance in nasopharyngeal carcinoma cells, and ectopic expression of TWIST1 led to increased resistance to microtubule-disrupting agents, including paclitaxel and vincristine [74]. The gene discussed is TWIST1; the disease is nasopharyngeal carcinoma.